Zurich Insurance Confirms $11 Billion Beazley Takeover
Zurich Insurance ZURN -0.30%decrease; down pointing triangle and Beazley BEZ -0.08%decrease; down pointing triangle reached a deal to…
Novartis Profit Beats Estimates, Signals Return to Growth
Novartis AG reported higher-than-expected profit last quarter as newer cancer medicines offset the aging blockbuster Entresto’s loss of…
Evan Greenberg, Chubb: Barron’s Top CEOs 2026
Evan Greenberg created the world’s top property and casualty insurer by engineering the merger of Ace, which he…
UBS’s Asia dealmaking bosses look to hold top three spot after Credit Suisse gains
Skip to main content Investment Banking The Swiss bank has added 100 bankers in the region from the…
Novartis to Buy Myricx Bio for Up to $1.5 Billion
Novartis NOVN -0.02%decrease; down pointing triangle said it agreed to pay up to $1.5 billion for Myricx Bio,…
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Novartis NOVN -1.20%decrease; red down pointing triangle said it agreed to buy biotech company Excellergy for up to…
Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools
Roche Holding ROP -1.01%decrease; red down pointing triangle said it agreed to buy PathAI for up to $1.05…
Wilson Sonsini Advises Foresight on Roche Settlement and Licensing Agreement
On August 29, 2025, Foresight Diagnostics, a privately held cancer diagnostics company and CLIA-registered laboratory, announced that it…
Nestlé Confirms Blue Bottle Sale to Luckin’s Largest Shareholder
A Blue Bottle Coffee location in Pudong, Shanghai, China. Nestlé has confirmed that it is selling Blue Bottle…
Zurich Insurance clinches £8.1b deal for marine insurer Beazley
London Gateway Port Port of London Authority London-listed speciality insurer Beazley said on Wednesday shareholders approved Swiss group Zurich…
Zurich Insurance clinches £8.1b deal for marine insurer Beazley
London-listed speciality insurer Beazley said on Wednesday shareholders approved Swiss group Zurich Insurance’s £8.1 billion ($10.94 billion) all-cash…
Novartis to Acquire Synnovation Unit in Deal Worth Up to $3 Billion
WILMINGTON, DE — Novartis has agreed to acquire Pikavation Therapeutics, a subsidiary of Synnovation Therapeutics, in a deal…